Linus Rieder

Linus Rieder serves as Principal at 415C. He joined the team as an Associate in July 2019 and has managed dozens of Due Diligence processes and financings in various capacities. Linus currently serves as board observer at R3 Vascular (bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease) and Cardiac Success (innovative transcatheter procedure to treat HFrEF patients), as well as formerly serving as an observer for TRiCares (transcatheter tricuspid heart valve replacement). Prior to joining 415C, Linus worked for 4K Invest as an Associate in their Munich office and for RBC Capital Market’s London office as an Analyst in the Healthcare Investment Banking team.

Linus holds a BSc. (Hons.) from King’s College London as well as an MPhil from the University of Cambridge.